1. The cynomolgus monkey as a model for developmental toxicity studies: variability of pregnancy losses, statistical power estimates, and group size considerations;Jarvis;Birth Defects Res. Bl,2010
2. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2016 and 2017;Barrow;Reprod. Toxicol.,2018
3. Importance of cynomolgus monkeys in development of monoclonal antibody drugs;Iwasaki;Drug Metab. Pharmacokinet.,2019
4. The value of non-human primates in the development of monoclonal antibodies;Van Meer;Nat. Biotechnol.,2013
5. Non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals;ICH M3(R2),2009